Author:
Houssaini Mohammed Sqalli,Damou Meriem,Ismaili Nabil
Reference25 articles.
1. Global and Regional Estimates of the Incidence and Mortality for 38 Cancers: GLOBOCAN 2018;Ferlay,2018
2. Non–Small cell lung cancer: epidemiology, Risk Factors, Treatment, and Survivorship;Molina;Mayo Clin Proc,2008
3. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin Proc,2008
4. Osimertinib as adjuvant therapy in patients with stage IB–IIIA EGFR mutation positive (EGFRm) NSCLC after complete tumor resection: ADAURA;Herbst;J Clin Oncol,2020
5. CTONG1104: adjuvant gefitinib versus chemotherapy for resected N1-N2 NSCLC with EGFR mutation—Final overall survival analysis of the randomized phase III trial 1 analysis of the randomized phase III trial;Wu;J Clin Oncol 38,2020
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献